Treatment of 4T1 cells with the exosomal secretion inhibitor GW4869 or tetracycline-induced Rab27 knockdown significantly inhibited tumor growth and enhanced anti-PD-L1 efficacy (135). This evidence concerns the gene CD274 and neoplasm.